Change Together reports on prostate cancer

Sep 18, 2018
Change Together reports on prostate cancer

In the US, prostate cancer is among the most common cancers in men, coming second only to skin cancer.1

The five-year survival rate of local prostate cancer is nearly 100%.1 But the prognosis for those whose diagnosis comes later is not so encouraging – the five-year survival rate once the disease has spread is 30%.1 It means almost 29,500 of the 165,00 men expected to be diagnosed with the disease in 2018 will die.1

Advocacy groups across the USA are working to improve the lives of the men affected by prostate cancer, and their families. Here we take a look at some of the stories on Change Together that discuss prostate cancer.

Research rundown: investigating the biological reason for prostate cancer disparity in African American men

Study finds African-American men are at a higher risk of prostate cancer than European-American men because of the molecule interleukin-6.

Daddy’s Boys – a new play tackling prostate cancer disparity in African-American men

A new play is breaking the silence surrounding black America’s prostate cancer crisis. The Prostate Health Education Network (PHEN) is working with GDavis Productions on Daddy’s Boys, a play about prostate cancer and its impact on the family.

How prostate cancer education benefits the whole community – an interview with Ana Fadich of Men’s Health Network

The Dialogue on Men’s Health speaking tour saw hundreds of men find our more abut their risk of prostate cancer. Ana Fadich of the Men’s Health Network talks to Change Together about the importance of educating the whole family and how to reach those most in need.

Managing the practical side of prostate cancer

We shine the spotlight on ZERO – The End of Prostate Cancer. The advocacy group works to improve early detection, raise awareness and further research, all with the aim of bringing an end prostate cancer.

Every man counts in the fight against prostate cancer

As part of Prostate Cancer Awareness Month 2017, we caught up with Colony Brown, Vice President of Marketing and Communications at ZERO Cancer, about the organization’s ‘Faces of Hope’ social media campaign that highlighted real-life experiences of prostate cancer.

Celebrating success to educate – Us TOO’s plans for Prostate Cancer Awareness Month 2017

For Prostate Cancer Awareness Month 2017, we spoke to Chuck Strand, CEO of Us TOO, about how the organization spread the word and the resources it provides to people battling prostate cancer.

Patient story: advocacy support in the prostate cancer patient journey

In this personal story, a prostate cancer survivor and a care giver talk about their own experiences of cancer and the power of advocacy.

ZERO unveils Faces of Hope campaign to end prostate cancer

Social media is critical in helping ZERO achieve its objectives of reaching the men and their families impacted by prostate cancer, Colony Brown of ZERO, tells Change Together.

Horizon scanning in prostate cancer care

In prostate cancer, huge strides are being made in clinical research. We take a look at how treatments are moving away from one-size-fits-all approach and toward more defined and targeted methods of diagnosis and treatment.

Social media focus: Prostate Cancer Awareness Month 2016

We examine some of the key topics of discussion, most used hashtags, influential users and examples of good Twitter practice across Prostate Cancer Awareness Month.

Eliminating disparity in prostate cancer – an interview with Thomas A. Farrington of the Prostate Health Education Network

We speak to Thomas Farrington, president and founder of the Prostate Health Education Network, about the organization’s work and Annual African-American Prostate Cancer Disparity Summit.


  1. Net (2018). Prostate Cancer: Statistics. Available from: (accessed September 2018).
Change Together reports on prostate cancer

Astellas Patient Advocacy is a function within Corporate Affairs at Astellas that focuses on creating, building and maintaining third-party relationships. We serve as a conduit between Astellas and external stakeholders to help improve patient outcomes, improve access issues and address patients’ unmet needs head on.

Leave a Reply